Regulatory Rapporteur

	December 2006 Vol. 3, No. 12  - Focus Article
	In this issue: • New EU Regulation on paediatric medicines • Quality Systems approach to GMP for medical devices • Salaries in Regulatory Affairs

November 2006 Vol. 3, No. 11  - Focus Article
In this issue: • TOPRA Symposium reports • Aginus Kalis interviewed • Preparing for electronic submission

	October 2006 Vol. 3, No. 10  - Focus Article
	In this issue: • Effects of drug pricing policies • Key competences for regulatory affairs professionals • Devices: moving to ISO 13485: 2003

September 2006 Vol. 3, No. 9  - Focus Article
In this issue: • Legislation on medicinal gases • Review of the Prescription Drug User Fee Act • Named patient supply • Continuing Personal Development

	July / August 2006 Vol. 3, No.7/8  - Focus Article
	In this issue: • Focus on complementary/alternative medicines • Inaugural meeting of TOPRA North America • Regulation of ophthalmic products

June 2006 Vol. 3, No. 6  - Focus Article
In this issue: • Multilingual product information • Avian influenza • EU Devices directives update • Open eCTD forum

	May 2006 Vol. 3, No. 5  - Focus Article
	In this issue: • European risk management strategy • Incentives for SMEs • 10 years of EMEA CNS submissions - a rapidly acting sleep inducing agent • Consistency of Scientific Advice

April 2006 Vol 3, No. 4  - Focus Article
In this issue: • Future regulation of Advanced Therapy Products • Interview with Dr pekka Kurki • User testing of PILs • Regulatory Intelligence Update

	March 2006 Vol 3, No. 3  - Focus Article
	In this issue: • Advanced Therapy Medicinal Products • Homeopathic Medicines • Increase your word power - biotechnology definitions • Re-use of single devices • 10 years of EMEA CNS medicines - a new dual action antidepressant

February 2006 Vol 3, No. 2  - Focus Article
In this issue: • The role of immunoassays and bioassays • Impact of new pharamaceutical legislation • Pre-clinical challenges facing cell-based medicinal products

	January 2006 Vol 3, NO. 1  - Focus Article
	In this issue: • Focus on immunotoxicity guidelines • Assessing carcinogenicity in the absence of standard rodent carcinogenicity data • The value of regulatory information in clinical research • 10 years of EMEA CNS medicines - Anti-dementia treatments

Regulatory Rapporteur - Previous Years Regulatory Rapporteur 2004 Regulatory Rapporteur 2005